Inogen Inc INGN

Morningstar Rating
$6.57 +0.03 (0.38%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INGN is trading at a LOCK|f$y!C! premium.
Price
$6.54
Fair Value
LOCK|K@W@^KR
Uncertainty
LOCK|#xS
1-Star Price
LOCK|v@YBR%
5-Star Price
LOCK|P!xDgw
Economic Moat
LOCK|k$
Capital Allocation

News

Trading Information

Previous Close Price
$6.54
Day Range
$6.576.80
52-Week Range
$5.359.11
Bid/Ask
$6.56 / $6.58
Shares Outstanding
27.07M
Market Cap
$178.42M
Volume/Avg
130,687 / 327,785

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.50
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
1.06%

Company Profile

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
753

Valuation

Metric
INGN
Price/Earnings (Normalized)
Price/Book Value
0.98
Price/Sales
0.50
Price/Cash Flow
13.88
Price/Earnings
INGN

Financial Strength

Metric
INGN
Quick Ratio
2.47
Current Ratio
3.10
Interest Coverage
Quick Ratio
INGN

Profitability

Metric
INGN
Return on Assets (Normalized)
−3.01%
Return on Equity (Normalized)
−4.69%
Return on Invested Capital (Normalized)
−6.23%
Return on Assets
INGN

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|%gr!@HLOCK|F!Rz$164B
Stryker Corp
SYK
LOCK|K<Q^!Wc$LOCK|>#^$126B
Medtronic PLC
MDT
LOCK|%qj%SzLOCK|@K?Kb$107B
Boston Scientific Corp
BSX
LOCK|^$Zvj^LOCK|SP@^$67B
Edwards Lifesciences Corp
EW
LOCK|^v&SFM#^LOCK|tFj&^$53B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|DpnTm!LOCK|?<$29B
DexCom Inc
DXCM
LOCK|mV>@cV%LOCK|%vz%$29B
Koninklijke Philips NV ADR
PHG
LOCK|ZVWLOCK|@dh$27B
Steris PLC
STE
LOCK|s&k?$C>LOCK|bNv#$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|!JcN$Y$!LOCK|&!B$18B

Sponsor Center